RRM2 and neoplasm: With the aim of a joint global effort to find novel biomarkers and therapeutic targets for this deadly tumor, in the present study, we evaluated the immunohistochemical expression of three GIN-related proteins: cyclin F, RRM2, and SPDL1 with regard to clinicopathological characteristics and survival outcomes of PDAC patients.